Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Breast Cancer, Metastatic

ESMO-Congress-2023-Banner-1000x250px

Friday 20 October

Evolving Paradigms in Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates

01-Evolving-Paradigms-in-Hormone-Receptor-Positive-Breast-Cancer-ASTRAZENECA-thumb

Friday, 10:15 - 11:45
View the satellite invitation

Saturday 21 October

Focus On Individualised Care with CDK4/6 Inhibitors in HR+/HER2- Metastatic Breast Cancer

13-Focus-On-Individualised-Care-with-CDK4-6-Inhibitors-in-HRHER2-PFIZER-thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Millions of Lives. One Mission. Exploring the Potential of ADCs in Multiple Solid Tumours

20-Millions-of-Lives-One-Mission-Exploring-the-Potential-GILEAD-thumb

Saturday, 13:00 - 14:25
View the satellite invitation

Oncologists at the Helm of Translating Biomarker Insights into Actionable Patient Care

25-Oncologists-at-the-Helm-of-Translating-Biomarker-Insights-into-Actionable-Patient-Care-MSD-thumb

Saturday, 18:30 - 19:50
View the satellite invitation

Lines of Progress: Continuing to Improve Outcomes in Metastatic Breast Cancer

28-Lines-of-Progress-Continuing-to-Improve-Outcomes-in-Metastatic-GILEAD-thumb

Saturday, 18:30 - 20:00
View the satellite invitation

Sunday 22 October

The Multi-Tumor Toolkit: ADCs in Cancer Therapy

44-The-Multi-Tumor-Toolkit-ADCs-in-Cancer-Therapy-DAIICHI-SANKYO-thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Monday 23 October

Case by Case: Strategic Sequencing Considerations in 3L HER2+ Metastatic Breast Cancer (MBC)

49-Case-by-Case-Strategic-Sequencing-Considerations-in-3L-HER2-Metastatic-Breast-MBC-SEAGEN-thumb

Monday, 13:00 - 14:30
View the satellite invitation

Current and Upcoming Treatment Strategies after CDK4/6 Inhibitors for Patients with ER+/HER2- Advanced Breast Cancer

54-Current-and-Upcoming-Treatment-Strategies-after-CDK46-MENARINI-thumb

Monday, 18:30 - 20:00
View the satellite invitation

HER Future: Pathways to Better Care for Women with HER2+ Breast Cancer

57-HER-Future-Pathways-to-Better-Care-for-Women-with-HER2-Breast-ROCHE-thumb

Monday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.